Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 1.850
0.00 (0.00%)
At close: Oct 6, 2026
Pentixapharm Holding AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -15.03 | -16.51 | -13.06 | -7.64 | -1.96 | -2.49 |
Depreciation & Amortization | 0.22 | 0.26 | 0.07 | 0.15 | 0.11 | 0.11 |
Other Amortization | 3.47 | 3.47 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.41 | 0.2 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | 19.01 | - | - | - |
Other Operating Activities | -1.43 | -1.86 | -4.62 | 1.8 | -0.22 | 0.85 |
Change in Accounts Receivable | 1.13 | 7.05 | -7.64 | 0.41 | 0.01 | -0 |
Change in Accounts Payable | -3.37 | -10.59 | -0.21 | 2.34 | -0.22 | 0.16 |
Change in Other Net Operating Assets | - | - | -0.28 | 5.08 | 0.07 | 0.01 |
Operating Cash Flow | -14.6 | -17.97 | -6.73 | 2.13 | -2.2 | -1.37 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.63 | -0.62 | -4.94 | -4.05 | -2.73 |
Sale of Property, Plant & Equipment | - | - | - | 0.13 | - | - |
Cash Acquisitions | - | - | 8.24 | - | -4.07 | - |
Investment in Securities | - | - | - | -0.53 | - | - |
Investing Cash Flow | -0.02 | -0.63 | 7.61 | -5.35 | -8.12 | -2.73 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | - | - | 19.89 | 25.66 | - | 5.29 |
Other Financing Activities | - | - | 3.52 | -13.83 | 9.01 | -0 |
Financing Cash Flow | 4 | - | 23.41 | 11.83 | 9.01 | 5.29 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.01 | -0.01 | - | - | - | - |
Net Cash Flow | -10.61 | -18.61 | 24.29 | 8.62 | -1.3 | 1.19 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -14.62 | -18.6 | -7.35 | -2.81 | -6.24 | -4.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6040.50% | -3535.74% | -513.26% | -159.47% | -20141.94% | -6726.23% |
Free Cash Flow Per Share | -0.59 | -0.75 | -0.30 | -0.13 | - | - |
Levered Free Cash Flow | -9.87 | -12.86 | -12.05 | -6.87 | -6.54 | - |
Unlevered Free Cash Flow | -9.82 | -12.86 | -11.99 | -6.76 | -6.54 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 0 |
Cash Income Tax Paid | 0.04 | 0.06 | 0.06 | 0.03 | - | - |
Change in Working Capital | -2.24 | -3.53 | -8.13 | 7.82 | -0.14 | 0.16 |